Chojnacki C, Wisniewska-Jarosinska M, et al
Other factors that may contribute to nausea during retatrutide treatment include: Central nervous system effects : GLP-1 receptors are present in brain regions involved in nausea and vomiting, including the area postrema, and activation of these pathways is thought to contribute to the emetogenic effects of this drug class [15] [16] Dose escalation : Rapid increases in dose are more likely to provoke symptoms than gradual titration Individual variability : Genetic, metabolic, and lifestyle factors can influence how sensitive a person is to these effects Dietary habits : Eating large, fatty, or rich meals may worsen nausea in those taking GLP-1-based therapies These mechanisms are not unique to retatrutide and are shared to varying degrees across the entire class of incretin-based medicines
Denis, G
The glucagon receptor (GCGR) is activated by glucagon a hormone produced by pancreatic alpha cells that raises blood glucose and drives hepatic energy mobilisation
During the study, body weight and food intake were measured every 23 days as indicated and body composition was measured pre-treatment and post-treatment as indicated by nuclear magnetic resonance (EchoMRI)
Skin Health and Appearance Growth hormone supports collagen production, which is essential for healthy, youthful-looking skin